Analysis
Rethinking the appraisal and approval of drugs for type 2 diabetes
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5260 (Published 09 October 2015) Cite this as: BMJ 2015;351:h5260
Related articles
- Analysis Published: 03 June 2010; BMJ 340 doi:10.1136/bmj.c1672
- Analysis Published: 07 August 2012; BMJ 345 doi:10.1136/bmj.e4261
- Research Published: 26 July 2011; BMJ 343 doi:10.1136/bmj.d4169
- Analysis Published: 06 September 2011; BMJ 343 doi:10.1136/bmj.d4849
- Research Published: 24 November 2011; BMJ 343 doi:10.1136/bmj.d6898
- Analysis Published: 07 February 2012; BMJ 344 doi:10.1136/bmj.e55
See more
- Partha Kar: Don’t obstruct changeBMJ April 26, 2022, 377 o949; DOI: https://doi.org/10.1136/bmj.o949
- Government pulls £100m funding for weight management services after just a yearBMJ April 14, 2022, 377 o984; DOI: https://doi.org/10.1136/bmj.o984
- All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICEBMJ March 31, 2022, 376 o834; DOI: https://doi.org/10.1136/bmj.o834
- Young man who refused treatment for suspected type 1 diabetes died before palliative care plan was put in placeBMJ March 24, 2022, 376 o787; DOI: https://doi.org/10.1136/bmj.o787
- Diabetes kills 100 000 Americans for second year in a rowBMJ February 03, 2022, 376 o300; DOI: https://doi.org/10.1136/bmj.o300
Cited by...
- Insulin Downregulates the Transcriptional Coregulator CITED2, an Inhibitor of Proangiogenic Function in Endothelial Cells
- Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
- Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile
- Basing approval of drugs for type 2 diabetes on real world outcomes